171 related articles for article (PubMed ID: 36682608)
21. Vancomycin dosing in neutropenic patients.
Haeseker MB; Croes S; Neef C; Bruggeman CA; Stolk LM; Verbon A
PLoS One; 2014; 9(11):e112008. PubMed ID: 25390637
[TBL] [Abstract][Full Text] [Related]
22. Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies.
Wang H; Huang L; Wang J; Ni Y; Zhu Z; Gao P; Hu Y; Zhang L; Yang J; Fang L
Pharmacotherapy; 2020 Dec; 40(12):1201-1209. PubMed ID: 33070357
[TBL] [Abstract][Full Text] [Related]
23. [Correlation of pharmacokinetic parameters with serum vancomycin concentration in elderly patients with malignancies].
Sadoh S; Tsuji Y; Tsukamoto K
Yakugaku Zasshi; 2010 Jan; 130(1):69-73. PubMed ID: 20046068
[TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.
Zhao W; Zhang D; Fakhoury M; Fahd M; Duquesne F; Storme T; Baruchel A; Jacqz-Aigrain E
Antimicrob Agents Chemother; 2014 Jun; 58(6):3191-9. PubMed ID: 24663023
[TBL] [Abstract][Full Text] [Related]
25. Population Pharmacokinetics of Vancomycin Under Continuous Renal Replacement Therapy Using a Polymethylmethacrylate Hemofilter.
Yamazaki S; Tatebe M; Fujiyoshi M; Hattori N; Suzuki T; Takatsuka H; Uchida M; Suzuki T; Ishii I
Ther Drug Monit; 2020 Jun; 42(3):452-459. PubMed ID: 31913865
[TBL] [Abstract][Full Text] [Related]
26. Model-Informed Vancomycin Dosing Optimization to Address Delayed Renal Maturation in Infants and Young Children with Critical Congenital Heart Disease.
Shimamoto Y; Fukushima K; Mizuno T; Ichikawa H; Kurosaki K; Maeda S; Okuda M
Clin Pharmacol Ther; 2024 Feb; 115(2):239-247. PubMed ID: 37994537
[TBL] [Abstract][Full Text] [Related]
27. The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.
Nelson NR; Morbitzer KA; Jordan JD; Rhoney DH
Neurocrit Care; 2019 Feb; 30(1):126-131. PubMed ID: 30051194
[TBL] [Abstract][Full Text] [Related]
28. A simple scoring method to predict augmented renal clearance in haematologic malignancies.
Saito K; Kamio S; Ito K; Suzuki N; Abe K; Goto T
J Clin Pharm Ther; 2020 Oct; 45(5):1120-1126. PubMed ID: 32497262
[TBL] [Abstract][Full Text] [Related]
29. [PK/PD of vancomycin in patients with severe acute pancreatitis combined with augmented renal clearance].
He J; Mao E; Jing F; Jiang H; Xu W; Yang W; Chen E
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):810-814. PubMed ID: 28936957
[TBL] [Abstract][Full Text] [Related]
30. Optimizing Vancomycin Dosing and Monitoring in Neonates and Infants Using Population Pharmacokinetic Modeling.
Jarugula P; Akcan-Arikan A; Munoz-Rivas F; Moffett BS; Ivaturi V; Rios D
Antimicrob Agents Chemother; 2022 Apr; 66(4):e0189921. PubMed ID: 35293782
[TBL] [Abstract][Full Text] [Related]
31. Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Cho YJ; Corley A; Diehl A; Gilder E; Jakob SM; Kim HS; Levkovich BJ; Lim SY; McGuinness S; Parke R; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Fraser JF; Shekar K; Roberts JA;
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0137721. PubMed ID: 34633852
[TBL] [Abstract][Full Text] [Related]
32. A population pharmacokinetic model of methotrexate in Korean patients with haematologic malignancy.
Jung YS; Son M; Lee SG; Chong JW; Kim SJ; Jang JE; Lyu CJ; Hahn SM; Han JW; Park K
Br J Clin Pharmacol; 2024 Mar; 90(3):849-862. PubMed ID: 37984417
[TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetic analysis of vancomycin in patients with hematological malignancies.
Buelga DS; del Mar Fernandez de Gatta M; Herrera EV; Dominguez-Gil A; García MJ
Antimicrob Agents Chemother; 2005 Dec; 49(12):4934-41. PubMed ID: 16304155
[TBL] [Abstract][Full Text] [Related]
34. Population Pharmacokinetic Model for Vancomycin Used in Open Heart Surgery: Model-Based Evaluation of Standard Dosing Regimens.
Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686154
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of Vancomycin among Patients with Chemotherapy-Associated Febrile Neutropenia: Which Would Be the Best Dosing to Obtain Appropriate Exposure?
Parra González D; Pérez Mesa JA; Cuervo Maldonado SI; Díaz Rojas JA; Cortés JA; Silva Gómez E; Saavedra Trujillo CH; Gómez J
Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36358178
[TBL] [Abstract][Full Text] [Related]
36. Population Pharmacokinetic Analysis of Doripenem after Intravenous Infusion in Korean Patients with Acute Infections.
Lee DH; Kim YK; Jin K; Kang MJ; Joo YD; Kim YW; Moon YS; Shin JG; Kiem S
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223378
[TBL] [Abstract][Full Text] [Related]
37. Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization.
Guilhaumou R; Marsot A; Dupouey J; Galambrun C; Boulamery A; Coze C; Simon N; André N
Ther Drug Monit; 2016 Oct; 38(5):559-66. PubMed ID: 27631462
[TBL] [Abstract][Full Text] [Related]
38. Parameters influencing the pharmacokinetics/pharmacodynamics of piperacillin/tazobactam in patients with febrile neutropenia and haematological malignancy: a prospective study.
Benech N; Dumitrescu O; Conrad A; Balsat M; Paubelle E; Ducastelle-Lepretre S; Labussière-Wallet H; Salles G; Cohen S; Goutelle S; Ader F;
J Antimicrob Chemother; 2019 Sep; 74(9):2676-2680. PubMed ID: 31219562
[TBL] [Abstract][Full Text] [Related]
39. Model-based Voriconazole Dose Optimization in Chinese Adult Patients With Hematologic Malignancies.
Liu Y; Qiu T; Liu Y; Wang J; Hu K; Bao F; Zhang C
Clin Ther; 2019 Jun; 41(6):1151-1163. PubMed ID: 31079860
[TBL] [Abstract][Full Text] [Related]
40. Vancomycin pharmacokinetics in critically ill patients receiving continuous haemodiafiltration with a polyethyleneimine-coated polyacrylonitrile membrane.
Tsuruyama M; Yamashina T; Tsuruta M; Tsukada H; Fujimoto A; Nagano M; Kawamata Y; Takashima S; Hiraki Y
J Clin Pharm Ther; 2020 Oct; 45(5):1143-1148. PubMed ID: 32497268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
